VIDEOS

Leveraging decades of experience conducting safety assessment, Altasciences offers a full range of in vivo GLP and non-GLP preclinical evaluation studies in multiple species to thoroughly assess the safety profile of your molecules.

We are a forward-thinking, mid-size contract research organization with locations in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to preclinical and early phase clinical studies, from lead candidate selection to proof of concept.

Altasciences has significant experience in cannabis, nicotine and tobacco product studies, both in the U.S. and Canada. We are invited members of the CORESTA (Cooperation Center for Scientific Research Relative to Tobacco) subcommittee on Smoking Behavior and Biomarkers, where we actively contribute to white papers concerning the latest requirements for clinical pharmacology studies needed for regulatory submission.

Imagine partnering with a team that you trust and telling your story once. Imagine a world where everyone and every project is of equal importance. Just imagine…

At Altasciences, we design driving studies to achieve your objectives, leveraging extensive experience across clinical testing of cognitive effects. We partner with Cognitive Research Corporation to use their proprietary driving simulators, nine of which are permanently installed in our clinic. We have performed well over 10,000 simulated drives to date.

Our experts in the design and conduct of clinical pharmacology and early efficacy studies ensure that data generated meets your objectives — working with you to leverage preclinical data in the design of the studies that take your programs through to proof of concept.